BioLife Sciences BLFE Stock
BioLife Sciences Price Chart
BioLife Sciences BLFE Financial and Trading Overview
| BioLife Sciences stock price | 0.0001 USD |
| Previous Close | 0.0002 USD |
| Open | 0.0002 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 9.8E-5 - 0.0002 USD |
| 52 Week Range | 5.0E-5 - 0.22 USD |
| Volume | 82.17M USD |
| Avg. Volume | 42.59M USD |
| Market Cap | 5.91K USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BLFE Valuation Measures
| Enterprise Value | 393.8K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
BioLife Sciences Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -99.91% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.22 USD |
| 52 Week Low | 5.0E-5 USD |
| 50-Day Moving Average | 0.0002 USD |
| 200-Day Moving Average | 0.00884895 USD |
BLFE Share Statistics
| Avg. Volume (3 month) | 42.59M USD |
| Avg. Daily Volume (10-Days) | 46.63M USD |
| Shares Outstanding | 0 |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:75 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | February 28, 2022 |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 15.62K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 398K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | -0.002 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of BioLife Sciences
| Country | United States |
| State | ON |
| City | Mississauga |
| Address | 5285 Bradco Blvd |
| ZIP | L4W 2A6 |
| Phone | 833-919-1037 |
| Website | https://www.biolifesciences.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature screening technology. It offers disinfecting wipes, UV sterilization technology, electrostatic disinfection services, anti-microbial textiles, and touchless vending/marketplaces products. Bio Life Sciences Corp. was incorporated in 2018 and is based in Mississauga, Canada.
Q&A For BioLife Sciences Stock
What is a current BLFE stock price?
BioLife Sciences BLFE stock price today per share is 0.0001 USD.
How to purchase BioLife Sciences stock?
You can buy BLFE shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioLife Sciences?
The stock symbol or ticker of BioLife Sciences is BLFE.
Which industry does the BioLife Sciences company belong to?
The BioLife Sciences industry is Medical Instruments & Supplies.
How many shares does BioLife Sciences have in circulation?
The max supply of BioLife Sciences shares is 3.18B.
What is BioLife Sciences Price to Earnings Ratio (PE Ratio)?
BioLife Sciences PE Ratio is now.
What was BioLife Sciences earnings per share over the trailing 12 months (TTM)?
BioLife Sciences EPS is -0.04 USD over the trailing 12 months.
Which sector does the BioLife Sciences company belong to?
The BioLife Sciences sector is Healthcare.